4.7 Article

The GSH responsive indocyanine green loaded PD-1 inhibitory polypeptide AUNP12 modified MOF nanoparticles for photothermal and immunotherapy of melanoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Multidisciplinary

A Multilayered Mesoporous Gold Nanoarchitecture for Ultraeffective Near-Infrared Light-Controlled Chemo/Photothermal Therapy for Cancer Guided by SERS Imaging

Bohan Yin et al.

Summary: A multifunctional theragnostic nanoplatform, consisting of mesoporous silica-coated gold nanostar with a cyclic Arg-Gly-Asp (RGD)-coated gold nanocluster shell, is reported. This nanoplatform exhibits enhanced SERS signals, improved NIR-induced photothermal conversion efficiency, high drug loading efficiency, and effective NIR-triggered drug release. It shows excellent performance in tumor targeting and achieves ultraeffective therapy in tumor cells and mouse models with NIR irradiation. This study offers a promising approach to effective noninvasive tumor treatment using SERS imaging and on-site triggered chemo-PTT.
Article Engineering, Biomedical

RGD peptide modified platinum nanozyme Co-loaded glutathione-responsive prodrug nanoparticles for enhanced chemo-photodynamic bladder cancer therapy

Ying Hao et al.

Summary: To enhance the therapeutic effect of chemo-photodynamic therapy for bladder cancer, researchers constructed a tumor-targeting peptide modified platinum nanozyme, which co-loaded glutathione-responsive prodrug nanoparticles. This system achieved GSH-responsive drug release in tumor microenvironment, enhanced drug accumulation and permeability at tumor sites, and alleviated tumor tissue hypoxia, providing new strategies and methods for clinical treatment of bladder cancer.

BIOMATERIALS (2023)

Article Engineering, Biomedical

Self-driven nanoprodrug platform with enhanced ferroptosis for synergistic photothermal-IDO immunotherapy

Ping Huang et al.

Summary: We report a multifunctional nanoprodrug platform that combines ferroptosis, photothermal therapy, and immunotherapy to awaken immune responses and block the indoleamine 2,3-diox-ygenase (IDO) pathway, thereby overcoming the limitations of tumor immunotherapy. The platform improved the delivery efficiency of indoximod (IND) and strengthened immune response through the self-driven release of IND and the amplification of oxidative stress. This study provides a new perspective on immunotherapeutics for cancer treatment.

BIOMATERIALS (2023)

Review Chemistry, Multidisciplinary

Stimuli-Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy

Jin Zhang et al.

Summary: This review discusses the use of stimuli-responsive nanoparticles (srNPs) in cancer immunotherapy, highlighting their potential to enhance anti-tumor immune responses by combining with tumor microenvironment and external stimuli. The goal is to achieve synergistic immunotherapy and long-term immune memory to prevent tumor recurrence.

ADVANCED SCIENCE (2022)

Review Biotechnology & Applied Microbiology

Two-dimensional metal-organic frameworks: from synthesis to bioapplications

Weiqi Wang et al.

Summary: This review article highlights the unique structural properties of ultrathin metal-organic framework nanosheets and their advantages in technological applications. It summarizes the design strategies and fabrication methods, and presents the recent advancements in the bioapplications of two-dimensional metal-organic frameworks and future opportunities.

JOURNAL OF NANOBIOTECHNOLOGY (2022)

Review Pharmacology & Pharmacy

Nanoscale MOFs: From synthesis to drug delivery and theranostics applications

Mengli Ding et al.

Summary: This review discusses the applications of metal-organic frameworks (MOFs) in drug delivery systems, including green synthesis, functional coating, drug encapsulation, and release mechanisms. It also introduces MOFs-based imaging techniques and cancer therapy methods.

ADVANCED DRUG DELIVERY REVIEWS (2022)

Review Chemistry, Multidisciplinary

Recent Advances in Hyperthermia Therapy-Based Synergistic Immunotherapy

Mengyu Chang et al.

Summary: Hyperthermia therapy has emerged as a strategy against malignant tumors, particularly when combined with nanomaterial-based photothermal therapy or magnetic hyperthermia. While these treatments alone may not completely cure cancer, when combined with cancer immunotherapy, they have shown potential for enhanced therapeutic outcomes against both primary tumors and metastatic lesions, as well as preventing cancer recurrence and prolonging survival period.

ADVANCED MATERIALS (2021)

Article Chemistry, Multidisciplinary

In situ vaccination and gene-medeiated PD-L1 blockade for enhanced tumor immunotherapy

Yingying Hu et al.

Summary: The researchers proposed a synergistic strategy combining in situ vaccination and gene-mediated anti-PD therapy, delivering CpG and pshPD-L1 genes using PEI as the carrier to form nanoparticles which showed synergistic antitumor efficacy in a mouse tumor model.

CHINESE CHEMICAL LETTERS (2021)

Article Chemistry, Multidisciplinary

Tumor microenvironment triggered local oxygen generation and photosensitizer release from manganese dioxide mineralized albumin-ICG nanocomplex to amplify photodynamic immunotherapy efficacy

Ning Jiang et al.

Summary: The utilization of manganese chloride to mineralize ICG@BSA polymer nanoparticles solves the issues of oxygen deficiency and drug safety in PDT. These nanoparticles circulate in the body for an extended period, releasing ICG at the tumor site and reversing the tumor hypoxia microenvironment, leading to enhanced efficacy of PDT without causing side effects.

CHINESE CHEMICAL LETTERS (2021)

Review Pharmacology & Pharmacy

PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy

Jinhua Liu et al.

Summary: Programmed death protein 1 (PD1) is an important immune checkpoint on T cells that plays a crucial role in downregulating the immune system and promoting self-tolerance, while its ligand, programmed cell death ligand 1 (PDL1), is overexpressed in malignant tumor cells, contributing to immune evasion and treatment failure. Despite the clinical efficacy of PD1/PDL1 inhibitors in many tumors, some patients may develop drug resistance, highlighting the need for further research into improving targeted therapies and understanding the associated safety issues.

FRONTIERS IN PHARMACOLOGY (2021)

Review Medicine, Research & Experimental

Cancer immunotherapy: Pros, cons and beyond

Shuzhen Tan et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Article Nanoscience & Nanotechnology

An Injectable, Near-Infrared Light-Responsive Click Cross-Linked Azobenzene Hydrogel for Breast Cancer Chemotherapy

Yuwen Chen et al.

JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2019)

Article Chemistry, Multidisciplinary

Antibodies@MOFs: An In Vitro Protective Coating for Preparation and Storage of Biopharmaceuticals

Yifan Feng et al.

ADVANCED MATERIALS (2019)

Review Oncology

Lessons learned from the blockade of immune checkpoints in cancer immunotherapy

Xiaolei Li et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)

Review Oncology

Targeting adenosine for cancer immunotherapy

Robert D. Leone et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)

Review Chemistry, Multidisciplinary

Integration of Biomolecules with Metal-Organic Frameworks

Jia Zhuang et al.

Article Chemistry, Multidisciplinary

ATP-Responsive Aptamer-Based Metal-Organic Framework Nanoparticles (NMOFs) for the Controlled Release of Loads and Drugs

Wei-Hai Chen et al.

ADVANCED FUNCTIONAL MATERIALS (2017)

Article Chemistry, Multidisciplinary

A new zirconium inorganic building brick forming metal organic frameworks with exceptional stability

Jasmina Hafizovic Cavka et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)